Webinars
-
Innovations en traitement hélicoïdal des Irradiations Corporelles Totales et Ostéo-médullaires : Expérience de La Pitié-Salpêtrière avec le systeme Radixact®
Ce webinaire est destiné aux équipes qui s’intéressent et qui souhaiteraient démarrer les irradiations corporelles ou ostéo-médullaires totales hélicoïdales. Seront abordées toutes les étapes ayant amené le service de Radiothérapie de l’Hôpital Pitié-Salpêtrière (AP-HP Sorbonne Université, Paris) à débuter cette technique innovante en 2012 avec la TomoTherapy® Hi-Art, jusqu’à sa transposition sur le Radixact® en […] The post Innovations en traitement hélicoïdal des Irradiations Corporelles Totales et Ostéo-médullaires : Expérience de La Pitié-Salpêtrière avec le systeme Radixact® appeared first on Accuray Exchange.
-
Use of the TomoTherapy® System for Nasopharyngeal Carcinoma
Nasopharyngeal carcinoma (NPC) is endemic in southern China, including Hong Kong, Southeast Asia and North Africa... The post Use of the TomoTherapy® System for Nasopharyngeal Carcinoma appeared first on Accuray Exchange.
-
Advancing the Role of Radiation Therapists: Exploring the Australian Experience
Celebrate World Radiography Day by attending a webinar dedicated to Radiation Therapy Technologists (RTTs). Engage with experts discussing the advances of the RTT role and its impact on patient care. The post Advancing the Role of Radiation Therapists: Exploring the Australian Experience appeared first on Accuray Exchange.
-
Institutional Experience with the World’s First Deep Inspiration Breath Hold (DIBH) Patient Treatment on the Radixact® X9 Enabled with VitalHold™
Joins us for this webinar for India... The post Institutional Experience with the World’s First Deep Inspiration Breath Hold (DIBH) Patient Treatment on the Radixact® X9 Enabled with VitalHold™ appeared first on Accuray Exchange.
-
Evidence, Outcomes and Practical Guidance to SABR in Primary Renal Cell Carcinoma for Your Clinic
Join us for this webinar to learn from Prof. Shankar Siva, an expert on SABR for primary renal cell carcinoma. The post Evidence, Outcomes and Practical Guidance to SABR in Primary Renal Cell Carcinoma for Your Clinic appeared first on Accuray Exchange.
-
Lösungsansätze für komplexe Bestrahlungskonzepte in der modernen Strahlentherapie
Webinar zu Lösungsansätzen für komplexe Zielvolumina und Dosisverschreibungen in der Strahlentherapie. The post Lösungsansätze für komplexe Bestrahlungskonzepte in der modernen Strahlentherapie appeared first on Accuray Exchange.
-
Overview of Reimbursement & Update on Payment Landscape
Don't miss the upcoming regional webinar for the USA, which will offer insights into the proposed reimbursement rules for 2025. The post Overview of Reimbursement & Update on Payment Landscape appeared first on Accuray Exchange.
-
Controversies and Evidence: Pelvic Lymph Node Management in High-Risk Prostate Cancer
Join us during Prostate Cancer Awareness Month to hear from one of the leading experts in the field, presenting on the important issue of pelvic lymph node management in high-risk prostate cancer. The post Controversies and Evidence: Pelvic Lymph Node Management in High-Risk Prostate Cancer appeared first on Accuray Exchange.
Disclaimer: The statements in this forum do not necessarily reflect the views of, and are not endorsed by, Accuray Incorporated or its affiliates. Such statements are not and should not be construed as medical, legal or reimbursement advice. To protect your privacy and the privacy of others, we ask that you do not provide to Accuray and/or to other members on this forum any information which contain personally identifiable information, including protected health information (as defined in 45 CFR §160.103 or applicable international regulations) or any sensitive information. Any health economic and reimbursement information contained herein may not be current or accurate as a result of complex and frequently changing laws, rules and policies.
By posting and submitting any content or information, you agree to comply with the Accuray Exchange Terms of Use. Remove or block out any patient-identifying information such that it cannot be accessed.